Kyle Wilson is a Partner at BroadOak and leads the firm’s M&A advisory activities. With over 25 years of investment banking experience, Kyle’s background includes broad transaction experience in both capital formation and mergers and acquisitions. Kyle joined BroadOak in 2011 and built the firm’s San Francisco office. Prior to BroadOak, Kyle was a Principal at Canaccord Genuity where he led the tools and diagnostics team and completed over $1.4 billion in life sciences transactions. Kyle was also a Vice President at RBC Capital markets where he successfully executed over $700 million in transactions. He is a member of the advisory board of Slone Partners and board member of Techcyte, Inc.
Kyle holds a B.S. in Business Administration, a Juris Doctorate and M.B.A., all from the University of Oklahoma. He is a much better golfer than Bill, but does suspect Bill is better at tennis.
The scale and dynamics of our industry sector have changed dramatically since BroadOak’s start 15 years ago. Our clients and partners continue to appreciate the consistency of our core focus and approach.
With unmatched experience and expertise, we help life sciences companies achieve their goals.